Sudarshan Pharma [SUDARSHAN] vs Gujarat Alkalies [GUJALKALI] Detailed Stock Comparison

Sudarshan Pharma

BSE

Gujarat Alkalies

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sudarshan Pharma wins in 7 metrics, Gujarat Alkalies wins in 10 metrics, with 0 ties. Gujarat Alkalies appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Sudarshan Pharma	Gujarat Alkalies	Better
P/E Ratio (TTM)	48.45	70.12	Sudarshan Pharma
Price-to-Book Ratio	5.85	0.69	Gujarat Alkalies
Debt-to-Equity Ratio	129.85	9.30	Gujarat Alkalies
PEG Ratio	N/A	-1.02	N/A
EV/EBITDA	19.49	11.20	Gujarat Alkalies
Profit Margin (TTM)	3.83%	-0.82%	Sudarshan Pharma
Operating Margin (TTM)	6.99%	1.34%	Sudarshan Pharma
EBITDA Margin (TTM)	6.99%	1.34%	Sudarshan Pharma
Return on Equity	12.14%	-1.08%	Sudarshan Pharma
Return on Assets (TTM)	3.96%	-0.78%	Sudarshan Pharma
Free Cash Flow (TTM)	$304.76M	$557.40M	Gujarat Alkalies
Dividend Yield	N/A	2.38%	N/A
1-Year Return	-79.44%	-25.66%	Gujarat Alkalies
Price-to-Sales Ratio (TTM)	1.40	0.99	Gujarat Alkalies
Enterprise Value	$9.38B	$45.10B	Gujarat Alkalies
EV/Revenue Ratio	1.70	1.07	Gujarat Alkalies
Gross Profit Margin (TTM)	N/A	60.26%	N/A
Revenue per Share (TTM)	$23	$573	Gujarat Alkalies
Earnings per Share (Diluted)	$0.66	$-4.70	Sudarshan Pharma
Beta (Stock Volatility)	1.25	-0.34	Gujarat Alkalies

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Sudarshan Pharma vs Gujarat Alkalies Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Sudarshan Pharma	1.61%	8.72%	26.21%	8.39%	5.68%	-21.85%
Gujarat Alkalies	0.98%	4.85%	-4.27%	-3.81%	2.49%	-23.13%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Sudarshan Pharma	-79.44%	-37.69%	-37.69%	-37.69%	-37.69%	-37.69%
Gujarat Alkalies	-25.66%	-36.02%	51.96%	230.11%	392.12%	286.51%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Sudarshan Pharma (SUDARSHAN): View Full Stock Overview

Gujarat Alkalies (GUJALKALI): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Sudarshan Pharma vs Gujarat Alkalies

Metric	SUDARSHAN	GUJALKALI
Market Information
Market Cap i	₹7.70B	₹41.50B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	288,800	31,465
90 Day Avg. Volume i	368,933	69,100
Last Close	₹34.77	₹574.55
52 Week Range	₹24.69 - ₹452.70	₹483.60 - ₹900.00
% from 52W High	-92.32%	-36.16%
All-Time High	₹452.70 (Sep 30, 2024)	₹1,044.70 (May 02, 2022)
% from All-Time High	-92.32%	-45.00%
Growth Metrics
Quarterly Revenue Growth	0.46%	0.13%
Quarterly Earnings Growth	N/A	0.13%
Financial Health
Profit Margin (TTM) i	0.04%	-0.01%
Operating Margin (TTM) i	0.07%	0.01%
Return on Equity (TTM) i	0.12%	-0.01%
Debt to Equity (MRQ) i	129.85	9.30
Cash & Liquidity
Book Value per Share (MRQ)	₹5.46	₹819.92
Cash per Share (MRQ)	₹0.09	₹20.86
Operating Cash Flow (TTM) i	₹8.46M	₹-2,728,000,000
Levered Free Cash Flow (TTM) i	₹159.55M	₹-651,200,000
Dividends
Last 12-Month Dividend Yield i	N/A	2.38%
Last 12-Month Dividend i	N/A	₹13.85

Valuation & Enterprise Metrics Analysis: Sudarshan Pharma vs Gujarat Alkalies

Metric	SUDARSHAN	GUJALKALI
Price Ratios
P/E Ratio (TTM) i	48.45	70.12
Forward P/E i	N/A	6.53
PEG Ratio i	N/A	-1.02
Price to Sales (TTM) i	1.40	0.99
Price to Book (MRQ) i	5.85	0.69
Market Capitalization
Market Capitalization i	₹7.70B	₹41.50B
Enterprise Value i	₹9.38B	₹45.10B
Enterprise Value Metrics
Enterprise to Revenue i	1.70	1.07
Enterprise to EBITDA i	19.49	11.20
Risk & Other Metrics
Beta i	1.25	-0.34
Book Value per Share (MRQ) i	₹5.46	₹819.92

Financial Statements Comparison: Sudarshan Pharma vs Gujarat Alkalies

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SUDARSHAN	GUJALKALI
Revenue/Sales i	N/A	₹10.75B
Cost of Goods Sold i	N/A	₹4.00B
Gross Profit i	N/A	₹6.75B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	₹165.10M
EBITDA i	N/A	₹1.26B
Pre-Tax Income i	N/A	₹101.90M
Income Tax i	N/A	₹13.70M
Net Income (Profit) i	N/A	₹88.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SUDARSHAN	GUJALKALI
Cash & Equivalents i	₹5.51M	₹1.26B
Total Current Assets i	₹3.35B	₹10.55B
Total Current Liabilities i	₹2.60B	₹9.33B
Long-Term Debt i	₹104.60M	₹3.17B
Total Shareholders Equity i	₹1.31B	₹60.26B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹200.50M	₹45.83B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SUDARSHAN	GUJALKALI
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SUDARSHAN	GUJALKALI
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	288,800	31,465
Average Daily Volume (90 Day) i	368,933	69,100
Shares Outstanding i	240.66M	73.44M
Float Shares i	78.34M	17.12M
% Held by Insiders i	0.75%	0.78%
% Held by Institutions i	0.00%	0.04%

Dividend Analysis & Yield Comparison: Sudarshan Pharma vs Gujarat Alkalies

Metric	SUDARSHAN	GUJALKALI
Last 12-Month Dividend i	N/A	₹13.85
Last 12-Month Dividend Yield i	N/A	2.38%
3-Year Avg Annual Dividend i	N/A	₹15.80
3-Year Avg Dividend Yield i	N/A	2.07%
3-Year Total Dividends i	N/A	₹47.40
Ex-Dividend Date	N/A	Sep 19, 2024

Sudarshan Pharma [SUDARSHAN] vs Gujarat Alkalies [GUJALKALI] Detailed Stock Comparison